Neyssa Marina

Neyssa Marina

Sarcoma Program

Professional Education

  • Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1990)
  • Fellowship: St Jude Children's Research Hospital (1989) TN
  • Board Certification: Pediatrics, American Board of Pediatrics (1987)
  • Residency: University Pediatric Hospital (1986) Puerto Rico
  • Internship: University Pediatric Hospital (1984) Puerto Rico
  • Medical Education: University of Puerto Rico (1983) Puerto Rico
  • MS, Stanford University, Epidemiology (2011)
  • BS, University of PR, Mayaguez, Chemistry (1979)
  • MD, University of PR, Medicine (1983)
  • Residency, University of PR, Pediatrics (1986)
  • Fellowship, St. Jude Children's Hospital, Pediatric Hematology-Oncology (1989)

Honors & Awards

  • Alfa Omega Alfa Honor Society, Alfa Omega Alfa (1982)
  • Magna Cum Laude-Antoine Lavoiser Chemistry Award, University of PR, Mayaguez Campus (1979)
  • Phi Kappa Phi Honor Society, Phi Kappa Phi (1979)

Administrative Appointments

  • Associate Chief of Clinical Affairs, Pediatric Hematology-Oncology, Lucile Packard Children's Hospital (2006 - 2011)
  • Director of Hematology-Oncology Outpatient Clinic, Lucile Packard Children's Hospital (2000 - Present)
  • Director, Pediatric Hematology-Oncology Fellowship Program, Stanford University (2000 - 2008)
  • Oncology Section Chief, Stanford University, Division of Pediatric Hematology-Oncology (2013 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.